Literature DB >> 30190019

Initial Evaluation of the Patient with Waldenström Macroglobulinemia.

Jorge J Castillo1, Steven P Treon2.   

Abstract

The initial evaluation of the patient with Waldenström macroglobulinemia can be challenging. Not only is it a rare disease, but the clinical features can vary greatly from patient to patient. In this article, we aim at providing concise and practical recommendations for the initial evaluation of patients with Waldenström macroglobulinemia, specifically regarding history taking, physical examination, laboratory testing, bone marrow aspiration, and biopsy evaluation and imaging studies. We then review the most common special clinical situations seen in patients with Waldenström macroglobulinemia, especially anemia, hyperviscosity, cryoglobulinemia, peripheral neuropathy, extramedullary disease, Bing-Neel syndrome, and amyloidosis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloidosis; Anemia; Bing-Neel syndrome; Bone marrow aspiration; Cryoglobulinemia; Hyperviscosity; Peripheral neuropathy; Waldenström macroglobulinemia

Mesh:

Year:  2018        PMID: 30190019     DOI: 10.1016/j.hoc.2018.05.008

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  3 in total

1.  Primary central nervous system diffuse large B-cell lymphoma masqueraded as Bing-Neel syndrome: Steps in management and review of future directions.

Authors:  Lukas Delasos; Deep Phachu; Nishka Shetty; Melissa Sepulveda-Ramos; James Vredenburgh
Journal:  Clin Case Rep       Date:  2021-12-06

2.  Bing-Neel Syndrome: Real-Life Experience in Personalized Diagnostic Approach and Treatment.

Authors:  Dimitrios Kotsos; Sofia Chatzileontiadou; Athanasia Apsemidou; Anna Xanthopoulou; Aikaterini Rapi; Christina Frouzaki; Evdoxia Hatjiharissi
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

3.  Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study.

Authors:  Xuejiao Yin; Lei Chen; Fengjuan Fan; Han Yan; Yuyang Zhang; Zhenli Huang; Chunyan Sun; Yu Hu
Journal:  Front Oncol       Date:  2020-09-10       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.